AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2312038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine maintenance therapy
Number of subjects: 60
Study 2312038 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 60
Study 2312038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine treatment in patients with severe non-stenosing bulb deformity
Number of subjects: 60
Study 2312038 — intervention group
Group type: COMPARATOR
Intervention: No treatment in patients with severe non-stenosing bulb deformity
Number of subjects: 60
Study 2312038 — intervention group
Group type: COMPARATOR
Intervention: No treatment in patients with normal or mildly deformed bulb
Number of subjects: 60
Study 2312038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine treatment in patients with normal duodenal bulb morphology
Number of subjects: 60
Study 384941 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure (67 patients)
Number of subjects: 268
Study 384941 — intervention group
Group type: COMPARATOR
Intervention: Colostomy (72 patients)
Number of subjects: 268
Study 29935999 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRE)
Number of subjects: 108
Study 29935999 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 108
Study 29935999 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VRE and PE
Number of subjects: 108
Study 26370109 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-sample FIT
Number of subjects: 8197
Study 26370109 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-sample FIT
Number of subjects: 8197
Study 25485802 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus technique on the right side
Number of subjects: 32
Study 25485802 — intervention group
Group type: COMPARATOR
Intervention: Serial puncture technique on the left side
Number of subjects: 32
Study 25485802 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial puncture technique
Number of subjects: 32
Study 25485802 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus technique
Number of subjects: 32
Study 23680985 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management lifestyle physical activity intervention delivered by a health coach using a workbook and alternating one-on-one telephone counseling and computer-assisted telephone calls for 20 weeks.
Number of subjects: 0
Study 23680985 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 23680985 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management lifestyle physical activity intervention
Number of subjects: 0
Study 21118954 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy (RCT)
Number of subjects: 116
Study 21118954 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure of RCT-induced downregulation of survivin
Number of subjects: 116
Study 19263066 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative intravenous dexamethasone (0.5 mg/kg) combined with glossopharyngeal nerve block (3 ml of 0.5% bupivacaine)
Number of subjects: 0
Study 19263066 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative intravenous dexamethasone (0.5 mg/kg)
Number of subjects: 0
Study 19263066 — intervention group
Group type: COMPARATOR
Intervention: Glossopharyngeal nerve block (3 ml of 0.5% bupivacaine)
Number of subjects: 0
Study 16881949 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified consent process (consent form written at a sixth-grade level, read to participants, combined with 7 comprehension questions and targeted education, repeated until comprehension achieved)
Number of subjects: 204
Study 16881949 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower literacy (s-TOHFLA<23)
Number of subjects: 204
Study 16881949 — intervention group
Group type: EXPERIMENTAL
Intervention: Being black
Number of subjects: 204
Study 16881949 — intervention group
Group type: EXPERIMENTAL
Intervention: Not speaking English as a primary language
Number of subjects: 204
Study 14764931 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 20942
Study 14764931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20942
Study 11772265 — intervention group
Group type: EXPERIMENTAL
Intervention: New antifungal agents (terbinafine, itraconazole, fluconazole)
Number of subjects: 0
Study 11772265 — intervention group
Group type: COMPARATOR
Intervention: Ketoconazole
Number of subjects: 0
Study 11772265 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 0
Study 9238872 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilized stannous fluoride dentifrice (Crest Plus Gum Care, 0.454% SnF2)
Number of subjects: 0
Study 9238872 — intervention group
Group type: COMPARATOR
Intervention: Triclosan/copolymer dentifrice (Colgate Total, 0.30% triclosan, 2.0% Gantrez co‐polymer)
Number of subjects: 0
Study 9238872 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoride dentifrice (0.243% NaF)
Number of subjects: 0
Study 7944842 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (first or second intramuscular dose)
Number of subjects: 52
Study 7944842 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (revaccination)
Number of subjects: 52
Study 7944842 — intervention group
Group type: COMPARATOR
Intervention: Primary vaccination
Number of subjects: 52
Study 7944842 — intervention group
Group type: EXPERIMENTAL
Intervention: Revaccination
Number of subjects: 52
Study 3130253 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (1-3 g/day, stratified according to body weight)
Number of subjects: 22
Study 3130253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 29857756 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic-only stimulation
Number of subjects: 0
Study 29857756 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric-only stimulation
Number of subjects: 0
Study 29857756 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined stimulation
Number of subjects: 0
Study 29857756 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28787505 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction-based extraction device
Number of subjects: 383
Study 28787505 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic filtration device
Number of subjects: 383
Study 28787505 — intervention group
Group type: COMPARATOR
Intervention: Control (standard aortic cannula)
Number of subjects: 383
Study 26426148 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath‐Body‐Mind Workshop (BBMW)
Number of subjects: 29
Study 26426148 — intervention group
Group type: COMPARATOR
Intervention: Educational seminar
Number of subjects: 29
Study 23735514 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib plus dacarbazine
Number of subjects: 91
Study 23735514 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus dacarbazine
Number of subjects: 91
Study 20684895 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 20
Study 20684895 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 20
Study 18211616 — intervention group
Group type: EXPERIMENTAL
Intervention: Apricitabine with trimethoprim-sulphamethoxazole
Number of subjects: 0
Study 18211616 — intervention group
Group type: COMPARATOR
Intervention: Apricitabine alone
Number of subjects: 0
Study 18211616 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulphamethoxazole
Number of subjects: 0
Study 17010732 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (prostate-specific antigen testing, digital rectal examination, transrectal ultrasonography, sextant biopsies)
Number of subjects: 42376
Study 17010732 — intervention group
Group type: EXPERIMENTAL
Intervention: Second screening round
Number of subjects: 42376
Study 17010732 — intervention group
Group type: EXPERIMENTAL
Intervention: First screening round
Number of subjects: 42376
Study 12728489 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedicated with oral midazolam 0.5 mg.kg‐1 (group A (+); n = 19)
Number of subjects: 43
Study 12728489 — intervention group
Group type: COMPARATOR
Intervention: Without premedication (group A (‐); n = 12)
Number of subjects: 43
Study 12728489 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (7-12 months; n = 12)
Number of subjects: 43
Study 11122102 — intervention group
Group type: EXPERIMENTAL
Intervention: Guthrie card samples
Number of subjects: 0
Study 11122102 — intervention group
Group type: COMPARATOR
Intervention: Blood donors
Number of subjects: 0
Study 9115563 — intervention group
Group type: EXPERIMENTAL
Intervention: Trephination plus suturing (group TS)
Number of subjects: 64
Study 9115563 — intervention group
Group type: COMPARATOR
Intervention: Suturing alone (group S)
Number of subjects: 64
Study 1454316 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-plate Molteno implantation
Number of subjects: 132
Study 1454316 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-plate Molteno implantation
Number of subjects: 132
Study 6095706 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 0
Study 6095706 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study 31372099 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy and visceral manipulation
Number of subjects: 20
Study 31372099 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy and placebo visceral manipulation
Number of subjects: 20
Study 29967197 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose edoxaban regimen (60 mg QD)
Number of subjects: 3029
Study 29967197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-reduced higher dose edoxaban regimen (30 mg QD)
Number of subjects: 3029
Study 29967197 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose edoxaban regimen (30 mg QD)
Number of subjects: 3029
Study 29967197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-reduced lower dose edoxaban regimen (15 mg QD)
Number of subjects: 3029
Study 29967197 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of endogenous FXa activity
Number of subjects: 3029
Study 26675776 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy meal (skim milk, low-fat yogurt, cheese, and bread)
Number of subjects: 43
Study 26675776 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat meal (lean red meat, bread, and orange juice)
Number of subjects: 43
Study 26675776 — intervention group
Group type: COMPARATOR
Intervention: Red meat meal
Number of subjects: 43
Study 26675776 — intervention group
Group type: COMPARATOR
Intervention: Dairy meal
Number of subjects: 43
Study 24831970 — intervention group
Group type: EXPERIMENTAL
Intervention: Light/Dark (LD) environment
Number of subjects: 38
Study 24831970 — intervention group
Group type: COMPARATOR
Intervention: Continuous Light (LL) environment
Number of subjects: 38
Study 22219221 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK598809 (175 mg single oral dose)
Number of subjects: 0
Study 22219221 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK598809 (175 mg single oral dose) + Alcohol infusion
Number of subjects: 0
Study 22219221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20055569 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program
Number of subjects: 158
Study 20055569 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 158
Study 18209689 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational Angiography (RA)
Number of subjects: 78
Study 18209689 — intervention group
Group type: COMPARATOR
Intervention: Standard Angiography (SA)
Number of subjects: 78
Study 18209689 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of severity of stenoses
Number of subjects: 78
Study 15185803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oralgiene 60 Second Time Machine powered toothbrush
Number of subjects: 58
Study 15185803 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Mickey Mouse powered toothbrush
Number of subjects: 58
Study 15185803 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Oral‐B Rugrats 20)
Number of subjects: 58
Study 12474069 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg Ca(2+))
Number of subjects: 31
Study 12474069 — intervention group
Group type: COMPARATOR
Intervention: No calcium supplementation (control group)
Number of subjects: 31
Study 10036599 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel 75 micrograms/day
Number of subjects: 1320
Study 10036599 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel 30 micrograms/day
Number of subjects: 1320
Study 7584298 — intervention group
Group type: EXPERIMENTAL
Intervention: Three study-recall trials on Swahili-English translation equivalents
Number of subjects: 200
Study 2674028 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg xipamide + 30 mg triamterene (A)
Number of subjects: 30
Study 2674028 — intervention group
Group type: COMPARATOR
Intervention: 25 mg hydrochlorothiazide + 50 mg triamterene (B)
Number of subjects: 30
Study 29925915 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-out intervention
Number of subjects: 0
Study 29925915 — intervention group
Group type: COMPARATOR
Intervention: Opt-in intervention
Number of subjects: 0
Study 29925915 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis (EHR portal messaging)
Number of subjects: 0
Study 28624715 — intervention group
Group type: EXPERIMENTAL
Intervention: Group physical activity program (12 weeks)
Number of subjects: 26
Study 28624715 — intervention group
Group type: COMPARATOR
Intervention: Individual physical activity program (12 weeks)
Number of subjects: 26
Study 26308937 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual physical therapy
Number of subjects: 58
Study 26308937 — intervention group
Group type: EXPERIMENTAL
Intervention: Group class intervention
Number of subjects: 58
Study 26308937 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 58
Study 23584279 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-drop/low-heel height shoes (SHOES)
Number of subjects: 30
Study 23584279 — intervention group
Group type: COMPARATOR
Intervention: Foot strike retraining (TRAIN)
Number of subjects: 30
Study 20473910 — intervention group
Group type: EXPERIMENTAL
Intervention: TT genotype
Number of subjects: 2617
Study 19926547 — intervention group
Group type: EXPERIMENTAL
Intervention: Job strain
Number of subjects: 1236
Study 19926547 — intervention group
Group type: EXPERIMENTAL
Intervention: High control
Number of subjects: 1236
Study 17066964 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 45
Study 17066964 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 45
Study 14530147 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical message
Number of subjects: 141
Study 14530147 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative message
Number of subjects: 141
Study 14530147 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment manipulation
Number of subjects: 141
Study 11097613 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (50 mg/ml for 5 minutes)
Number of subjects: 113
Study 11097613 — intervention group
Group type: COMPARATOR
Intervention: mitomycin C (0.4 mg/ml for 2 minutes)
Number of subjects: 113
Study 11097613 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil
Number of subjects: 113
Study 11097613 — intervention group
Group type: COMPARATOR
Intervention: mitomycin C
Number of subjects: 113
Study 9387586 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-education group
Number of subjects: 0
Study 9387586 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-education group
Number of subjects: 0
Study 1561975 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing group (VVI or DDD pacemaker implant)
Number of subjects: 60
Study 1561975 — intervention group
Group type: COMPARATOR
Intervention: Nonpacing group (no therapy)
Number of subjects: 60
Study 3929304 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg metergoline (MET)
Number of subjects: 12
Study 3929304 — intervention group
Group type: COMPARATOR
Intervention: 10 mg diazepam (DZ)
Number of subjects: 12
Study 3929304 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 12
Study 29684147 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 167
Study 29684147 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer infusions of Meropenem
Number of subjects: 167
Study 29684147 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem for culture-proven Gram-negative LOS
Number of subjects: 167
Study 26041481 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidermal growth factor (EGF) ointment
Number of subjects: 52
Study 25111880 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 14224
Study 25111880 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 14224
Study 25111880 — intervention group
Group type: COMPARATOR
Intervention: Placebo (FIT)
Number of subjects: 14224
Study 25111880 — intervention group
Group type: COMPARATOR
Intervention: Placebo (HORIZON-PFT)
Number of subjects: 14224
Study 25111880 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled data from FIT and HORIZON-PFT
Number of subjects: 14224
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants aged 65 to 75 years
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with waist circumference ≥90 cm
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with grade 2 hypertension
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with grade 3 hypertension
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with heart rate at rest 70 to 80 beats/min
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with heart rate at rest ≥80 beats/min
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with poor sleeping quality
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Men inland versus coastal residents
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Women inland versus coastal residents
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with BMI ≥25 kg/m²
Number of subjects: 3128
Study 23146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with BMI ≥25 kg/m²
Number of subjects: 3128
Study 21516742 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alpha-lipoic acid (600 mg/day)
Number of subjects: 100
Study 21516742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 18059990 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps CAR in CAI group (involved limb)
Number of subjects: 41
Study 18059990 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps CAR in CAI group (uninvolved limb)
Number of subjects: 41
Study 18059990 — intervention group
Group type: COMPARATOR
Intervention: Quadriceps CAR in control group (sham involved)
Number of subjects: 41
Study 18059990 — intervention group
Group type: COMPARATOR
Intervention: Quadriceps CAR in control group (sham uninvolved)
Number of subjects: 41
Study 18059990 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstrings CAR in CAI group (averaged)
Number of subjects: 41
Study 18059990 — intervention group
Group type: COMPARATOR
Intervention: Hamstrings CAR in control group (averaged)
Number of subjects: 41
Study 15630501 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) therapy during the first weeks of life
Number of subjects: 0
Study 15630501 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) therapy
Number of subjects: 0
Study 15630501 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Epo therapy)
Number of subjects: 0
Study 12710842 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (5,000 IU per day for 14 days)
Number of subjects: 3300
Study 12710842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3300
Study 10188602 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted rehabilitation and measurement (ARM) Guide during guided movement
Number of subjects: 8
Study 10188602 — intervention group
Group type: COMPARATOR
Intervention: Assisted rehabilitation and measurement (ARM) Guide
Number of subjects: 8
Study 7586935 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (10 mmol sodium/24 hours)
Number of subjects: 7
Study 7586935 — intervention group
Group type: COMPARATOR
Intervention: High-sodium diet (250 mmol sodium/24 hours)
Number of subjects: 7
Study 2138172 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% ammonium lactate lotion (Lac‐Hydrin) applied twice daily for 16 weeks
Number of subjects: 58
Study 2138172 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 58
Study 7222872 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole prophylaxis
Number of subjects: 103
Study 7222872 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 103
Study 30744172 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise under normoxia (FIO₂: 0.209)
Number of subjects: 20
Study 30744172 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise under hypoxia (FIO₂: 0.154)
Number of subjects: 20
Study 30744172 — intervention group
Group type: COMPARATOR
Intervention: Moderate hypoxia (FIO₂: 0.154)
Number of subjects: 20
Study 28642340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fit obese (LF-OB, n=27)
Number of subjects: 70
Study 28642340 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fit obese (HF-OB, n=27)
Number of subjects: 70
Study 28642340 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese individuals (OB, LF-OB, HF-OB)
Number of subjects: 70
Study 28642340 — intervention group
Group type: COMPARATOR
Intervention: Age-matched healthy controls (AMHC, n=16)
Number of subjects: 70